L-arginine in the management of menopausal symptoms: vascular, metabolic, and quality-of-life effects (a systematic literature review)
Open Access
- 27 November 2025
- journal article
- Published by Professional Event, LLC in Reproductive health of woman
- No. 8,p. 122-128
Abstract
Menopause is a critical period in a woman’s life, which is accompanied by complex physiological, psycho-emotional, and metabolic changes that significantly affect quality of life. An important pathogenetic mechanism during this period is the development of endothelial dysfunction and the reduction of nitric oxide (NO) bioavailability, which leads to impaired vascular reactivity, increased risk of cardiovascular disease, and intensification of vasomotor symptoms (VMS). L-arginine, as the main substrate for NO synthase, is considered a promising non-hormonal agent for the correction of menopausal disorders, it is able to influence on vascular, metabolic, and sexual function, as well as the overall well-being of women in peri- and postmenopause. The aim of this work was to summarize current data on the role and clinical effectiveness of L-arginine in the management of menopausal symptoms.A systematic analytical review of clinical studies which were published in international databases (PubMed, Scopus, Cochrane Library, Web of Science) and local sources from 2010 to 2025 was conducted. The analysis included randomized controlled trials and large prospective cohort studies that evaluated the effectiveness of oral L-arginine of the following indications: reduction of the frequency and intensity of VMS, correction of menopausal endotheliopathy, improvement of sexual function, and its impact on microcirculation, lipid metabolism, glycemic markers, and the severity of climacteric syndrome (Kupperman index, Menopause-Specific Quality of Life Questionnaire – MENQOL, The Short Form-36 Health Survey – SF-36).The results of the analysis indicate that L-arginine contributes to a significant improvement in endothelial function, reduction of triglycerides, total cholesterol, low-density lipoproteins, and fasting glucose. In most studies, a statistically significant decrease in the Kupperman index and the frequency of VMS was observed, confirming its clinical effectiveness in correction of climacteric manifestations. Data on improvements in quality of life according to MENQOL and SF-36 scales remain heterogeneous, with the most pronounced effects reported in studies of combined nutrient supplements. At the same time, L-arginine is characterized by good tolerability and a favorable safety profile, with adverse effects limited to mild gastrointestinal symptoms.Thus, L-arginine is a promising non-hormonal agent in the management of menopausal symptoms due to its effect on the “L-arginine – NO – cyclic guanosine monophosphate – vasodilation” pathway. Its use improves vascular and metabolic parame-ters, reduces the severity of climacteric manifestations, and may positively influence sexual function and the overall well-being of women in peri- and postmenopause. Further large-scale randomized trials are needed to confirm these findings, standardize dosages, and determine the long-term effects of therapy.Keywords
This publication has 42 references indexed in Scilit:
- Exploring symptom clusters across the menopausal stages – systematic review and meta-analysisSexual & Reproductive Healthcare, 2025
- Role of Argininosuccinate Synthase 1 ‐Dependent L‐Arginine Biosynthesis in the Protective Effect of Endothelial Sirtuin 3 Against AtherosclerosisAdvanced Science, 2024
- Menopause—Biology, consequences, supportive care, and therapeutic optionsCell, 2023
- Effect of Vitamin-Containing Amino Acid Supplements on Menopausal Symptoms and Age-Related Skin Changes: A Randomised, Double-Blind, Placebo-Controlled StudyDermatology and Therapy, 2021
- Poor cerebrovascular function is an early marker of cognitive decline in healthy postmenopausal womenAlzheimer's & Dementia: Translational Research & Clinical Interventions, 2016
- Combined effects of aerobic exercise and l -arginine ingestion on blood pressure in normotensive postmenopausal women: A crossover studyLife Sciences, 2016
- Diminished Global Arginine Bioavailability as a Metabolic Defect in Chronic Systolic Heart FailureJournal of Cardiac Failure, 2013
- Citrulline and arginine utility in treating nitric oxide deficiency in mitochondrial disordersMolecular Genetics and Metabolism, 2012
- Role of l-Arginine on Dyslipidemic Conditions of Acute Myocardial Infarction PatientsIndian Journal of Clinical Biochemistry, 2012
- Endothelial dysfunction, ADMA and insulin resistance in essential hypertensionInternational Journal of Cardiology, 2010